Moomoo AI 已提取核心信息
Redmile Group, LLC, an investment adviser and parent holding company, along with its principal Jeremy C. Green, have filed an amended Schedule 13G with the SEC, indicating a change in their holdings of HOOKIPA Pharma Inc. As of December 31, 2023, Redmile Group and Mr. Green reported shared voting and dispositive power over 1,063,769 shares of HOOKIPA Pharma's common stock, representing 1.1% of the company's class. This filing, dated February 14, 2024, suggests that they no longer hold more than 5% of the company's securities. Both Redmile Group and Jeremy C. Green have disclaimed beneficial ownership of the reported shares, except to the extent of their pecuniary interest. The filing was made in accordance with Rule 13d-1(b) of the Securities Exchange Act of 1934, and the shares in question are held by private investment vehicles and/or sub-advised accounts managed by Redmile Group.
Redmile Group, LLC, an investment adviser and parent holding company, along with its principal Jeremy C. Green, have filed an amended Schedule 13G with the SEC, indicating a change in their holdings of HOOKIPA Pharma Inc. As of December 31, 2023, Redmile Group and Mr. Green reported shared voting and dispositive power over 1,063,769 shares of HOOKIPA Pharma's common stock, representing 1.1% of the company's class. This filing, dated February 14, 2024, suggests that they no longer hold more than 5% of the company's securities. Both Redmile Group and Jeremy C. Green have disclaimed beneficial ownership of the reported shares, except to the extent of their pecuniary interest. The filing was made in accordance with Rule 13d-1(b) of the Securities Exchange Act of 1934, and the shares in question are held by private investment vehicles and/or sub-advised accounts managed by Redmile Group.
投资顾问兼母控股公司Redmile Group, LLC及其负责人杰里米·格林已向美国证券交易委员会提交了经修订的附表13G，表示其持有的HOOKIPA Pharma Inc.发生了变化。截至2023年12月31日，Redmile集团和格林先生报告了对HOOKIPA Pharma普通股的1,063,769股股票的共同投票权和处置权，占该公司同类股票的1.1％。这份日期为2024年2月14日的文件表明，他们不再持有超过公司5％的证券。Redmile集团和Jeremy C. Green均宣布放弃对申报股票的实益所有权，但金钱权益除外。该文件是根据1934年《证券交易法》第13d-1（b）条提交的，有关股票由私人投资工具和/或由Redmile集团管理的次级建议账户持有。
投资顾问兼母控股公司Redmile Group, LLC及其负责人杰里米·格林已向美国证券交易委员会提交了经修订的附表13G，表示其持有的HOOKIPA Pharma Inc.发生了变化。截至2023年12月31日，Redmile集团和格林先生报告了对HOOKIPA Pharma普通股的1,063,769股股票的共同投票权和处置权，占该公司同类股票的1.1％。这份日期为2024年2月14日的文件表明，他们不再持有超过公司5％的证券。Redmile集团和Jeremy C. Green均宣布放弃对申报股票的实益所有权，但金钱权益除外。该文件是根据1934年《证券交易法》第13d-1（b）条提交的，有关股票由私人投资工具和/或由Redmile集团管理的次级建议账户持有。
有用
没用